SB 489 modifies Maryland's licensing rules for physicians trained at international medical schools. It exempts applicants who provide evidence of completing two years of postgraduate training accredited by ACGME-I or another board-recognized body from standard educational requirements. These physicians would be permitted to practice medicine only during their initial license term under mandatory supervision, as specified by the Board. The bill takes effect October 1, 2026, directly affecting international medical graduates meeting these specific training criteria.
HB 813 authorizes Maryland's Medicaid program (Maryland Medical Assistance Program) to cover comprehensive obesity treatment, including intensive behavioral therapy, bariatric surgery, and FDA-approved weight management medications, starting January 1, 2027. The bill requires the Maryland Department of Health to notify Medicaid recipients if it chooses to provide this coverage and mandates a report to the legislature by November 1, 2027, on implementation progress. This directly affects Medicaid recipients with obesity by expanding covered treatments beyond current scope. The program may use standard utilization management processes (like for other conditions) to assess medical necessity but is not required to offer the coverage.
This bill updates Maryland's newborn screening program by changing how fees are set and how new tests are added to the screening panel. It requires the Department of Health to charge fees that cover all administrative, laboratory, and follow-up costs rather than setting a specific maximum amount. The bill also establishes a process where an advisory council must review risks, costs, and accessibility before the department decides whether to test for new conditions added to the national screening panel. Additionally, it extends the timeline for implementing new tests to two years if equipment or supplies are delayed, with required reporting to state committees.
HB 989 modifies how income is calculated for elderly individuals seeking state assistance. It prohibits including rental income from a portion of an individual's primary residence (e.g., renting a room) when determining eligibility for state tax credits, housing assistance, or medical assistance programs. The Department of Aging must review all relevant programs to confirm applicability and notify administering agencies if the rule applies. This change directly affects elderly Marylanders who rely on state assistance programs with income-based eligibility requirements. The law takes effect July 1, 2026.
HB 921 limits when minors in Maryland juvenile facilities can be placed in restrictive housing (isolation or special confinement). It prohibits using restrictive housing for discipline, punishment, or staff convenience, and requires facilities to use it only for immediate safety risks (like harm to self/others or facility security) for the shortest time possible (max 6 hours). Minors can request restrictive housing or withdraw that request at any time, and facilities must provide mental health screenings within 1 hour of placement. The bill also mandates that minors in restrictive housing receive the same access to phone calls, visits, medical care, education, and recreation as other minors, unless safety is at risk.
HB 1617 establishes "Health Innovation Zones" in Maryland counties to address health disparities. It defines zones as areas with documented health gaps (like high maternal complications, chronic diseases, or low access to care) in communities of color, low-income areas, or immigrant populations. Counties must create incentives for grocery stores, pharmacies, and healthcare providers to locate in these zones, and Prince George’s County must designate specific zones (including the Blue Line Corridor and areas near DC) while seeking additional zones meeting the same criteria. The bill requires annual $5 million state funding starting in 2028 for the Maryland Economic Development Corporation to support these businesses and exempts them from local zoning laws within designated zones.
HB 883 prohibits AI developers from making or causing AI to make claims that the AI is a behavioral health provider or can deliver behavioral health care services. It requires AI sold to Maryland consumers to include clear notices stating users are interacting with AI (not a human) and to detect suicidal thoughts or self-harm, automatically referring users to crisis services. Violations carry civil penalties up to $1 million per offense, with funds directed to Maryland’s Behavioral Health Workgroup Investment Fund. The law directly affects AI developers and sellers operating in Maryland, focusing on preventing misleading AI interactions in mental health contexts.
HB 860, the Arnaud and Magruder Memorial Act, sets a 5-day initial limit for emergency evaluation petitions after court approval, with extensions of up to 5 days each (totaling no more than 30 days) based on the individual's current behavior. The bill requires courts to include the petition's expiration date and clarifies that peace officers must transport individuals to emergency facilities when holding a valid petition (either court-endorsed within 5 days or signed by authorized professionals), allowing electronic petitions. This law directly affects courts reviewing petitions, peace officers executing them, emergency facilities receiving individuals, and people subject to emergency evaluations. It standardizes timelines and procedures to ensure timely care while preventing prolonged detention without court review.
HB 1143 bans the use of the "lung float test" (a hydrostatic lung test) during perinatal autopsies in Maryland. It directly affects the Chief Medical Examiner, deputy examiners, assistant examiners, and authorized pathologists when determining if a death was a stillbirth or occurred after a live birth. The bill prohibits this specific test method and allows parents, guardians, or legal representatives to file a civil lawsuit if the test is used unlawfully. Violations also become grounds for disciplinary action against medical examiners.
HB 1150 expands pharmacists' scope of practice in Maryland to prescribe, administer, and dispense medications for specific minor conditions and HIV prevention/treatment under statewide protocols. It directly affects pharmacists (by allowing new clinical duties) and patients (by increasing access to care for conditions like cold sores, strep throat, flu, lice, urinary infections, and HIV testing). Key provisions include permitting pharmacists to prescribe for minor, self-limiting conditions without a new diagnosis and to perform/interpret HIV lab tests while prescribing PrEP/PEP medications. The bill repeals the previous nPEP standing order program and requires the Maryland Department of Health to establish these protocols.
